| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.805 | 0.004 | 0.878 | Anticonvulsant | 0.878 0.004 CID_4616 | CID_4616 | |
| 0.794 | 0.002 | 0.794 | GABA C receptor rho-3 antagonist | 0.668 0.004 CID_4616 | ||
| 0.66 | 0.003 | 0.706 | GABA receptor antagonist | 0.706 0.003 CID_4616 | CID_4616 | |
| 0.651 | 0.003 | 0.699 | GABA A receptor antagonist | 0.699 0.003 CID_4616 | CID_4616 | |
| 0.601 | 0.002 | 0.667 | Benzodiazepine agonist | 0.667 0.002 CID_4616 | CID_4616 | |
| 0.572 | 0.002 | 0.572 | GABA C receptor rho-2 antagonist | 0.344 0.004 CID_4616 | ||
| 0.574 | 0.007 | 0.574 | Psychostimulant | 0.568 0.007 CID_4616 | ||
| 0.529 | 0.007 | 0.529 | Sigma receptor agonist | |||
| 0.514 | 0.006 | 0.514 | Cyclic AMP phosphodiesterase inhibitor | 0.226 0.077 CID_4616 | ||
| 0.494 | 0.004 | 0.494 | Glutamate receptor antagonist | 0.174 0.036 CID_4616 | ||
| 0.482 | 0.004 | 0.637 | GABA receptor agonist | 0.637 0.003 CID_4616 | CID_4616 | |
| 0.469 | 0.003 | 0.469 | GABA C receptor antagonist | 0.218 0.01 CID_4616 | ||
| 0.464 | 0.052 | 0.464 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.38 0.119 CID_4616 | ||
| 0.455 | 0.048 | 0.455 | Calcium channel L-type activator | 0.279 0.175 CID_4616 | ||
| 0.417 | 0.014 | 0.417 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.322 0.03 CID_4616 | ||
| 0.419 | 0.067 | 0.419 | 5 Hydroxytryptamine release inhibitor | 0.358 0.108 CID_4616 | ||
| 0.355 | 0.002 | 0.355 | Purinergic P2X4 antagonist | 0.079 0.007 CID_4616 | ||
| 0.354 | 0.028 | 0.354 | Interleukin agonist | 0.195 0.126 CID_4616 | ||
| 0.345 | 0.025 | 0.577 | Anesthetic general | 0.577 0.005 CID_4616 | CID_4616 | |
| 0.365 | 0.045 | 0.365 | Aryl hydrocarbon receptor agonist | 0.264 0.073 CID_4616 | ||
| 0.334 | 0.015 | 0.334 | Gastrin inhibitor | 0.23 0.104 CID_4616 | ||
| 0.322 | 0.005 | 0.322 | Glutamate (mGluR group I) antagonist | |||
| 0.321 | 0.003 | 0.321 | GABA C receptor rho-1 antagonist | 0.191 0.01 CID_4616 | ||
| 0.322 | 0.005 | 0.322 | Glutamate (mGluR) antagonist | |||
| 0.337 | 0.028 | 0.337 | Platelet aggregation inhibitor | |||
| 0.352 | 0.048 | 0.352 | Calcium channel activator | |||
| 0.354 | 0.055 | 0.354 | 5 Hydroxytryptamine release stimulant | 0.181 0.139 CID_4616 | ||
| 0.326 | 0.048 | 0.458 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.458 0.012 CID_4616 | CID_4616 | |
| 0.254 | 0.012 | 0.254 | Death-associated protein kinase 2 inhibitor | 0.246 0.014 CID_4616 | ||
| 0.244 | 0.008 | 0.244 | Falcipain 2 inhibitor | |||
| 0.274 | 0.038 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.25 0.049 CID_4616 | ||
| 0.243 | 0.008 | 0.243 | Falcipain inhibitor | |||
| 0.248 | 0.014 | 0.248 | ATPase inhibitor | 0.202 0.036 CID_4616 | ||
| 0.278 | 0.049 | 0.278 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.161 0.102 CID_4616 | ||
| 0.22 | 0.01 | 0.22 | 5 Hydroxytryptamine 3A agonist | 0.116 0.059 CID_4616 | ||
| 0.203 | 0.004 | 0.203 | Glutamate (mGluR5) antagonist | |||
| 0.21 | 0.014 | 0.21 | Polo-like kinase-4 inhibitor | |||
| 0.236 | 0.043 | 0.236 | Nitric-oxide synthase stimulant | 0.206 0.079 CID_4616 | ||
| 0.201 | 0.012 | 0.218 | Interleukin 8 antagonist | 0.218 0.009 CID_4616 | CID_4616 | |
| 0.188 | 0.005 | 0.188 | Phosphodiesterase II inhibitor | |||
| 0.185 | 0.003 | 0.185 | Benzodiazepine antagonist | 0.133 0.003 CID_4616 | ||
| 0.216 | 0.037 | 0.216 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.176 | 0.005 | 0.176 | Phosphodiesterase 2A inhibitor | |||
| 0.175 | 0.005 | 0.175 | Bromodomain-containing protein 2 inhibitor | 0.103 0.037 CID_4616 | ||
| 0.183 | 0.017 | 0.183 | NMDA receptor antagonist | 0.118 0.036 CID_4616 | ||
| 0.226 | 0.066 | 0.226 | ErbB-1 antagonist | 0.175 0.124 CID_4616 | ||
| 0.297 | 0.138 | 0.297 | MAP kinase kinase 6 inhibitor | 0.226 0.225 CID_4616 | ||
| 0.244 | 0.087 | 0.244 | 5 Hydroxytryptamine uptake stimulant | 0.192 0.168 CID_4616 | ||
| 0.182 | 0.031 | 0.182 | Platelet activating factor antagonist | |||
| 0.156 | 0.006 | 0.156 | Glycine receptor antagonist | 0.146 0.008 CID_4616 | ||
| 0.183 | 0.036 | 0.183 | Sodium channel (voltage-gated) blocker | |||
| 0.166 | 0.02 | 0.166 | DNA directed RNA polymerase inhibitor | |||
| 0.161 | 0.016 | 0.283 | Potassium channel activator | 0.283 0.005 CID_4616 | CID_4616 | |
| 0.147 | 0.004 | 0.147 | GABA B receptor antagonist | 0.053 0.017 CID_4616 | ||
| 0.166 | 0.023 | 0.166 | Potassium channel (Ca-activated) activator | 0.096 0.059 CID_4616 | ||
| 0.203 | 0.061 | 0.203 | LIM domain kinase 1 inhibitor | |||
| 0.154 | 0.013 | 0.197 | Cyclin B3 inhibitor | 0.197 0.006 CID_4616 | CID_4616 | |
| 0.234 | 0.093 | 0.234 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.214 | 0.073 | 0.214 | MAP kinase kinase 2 inhibitor | |||
| 0.201 | 0.061 | 0.201 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.183 | 0.046 | 0.183 | Cyclin-dependent kinase 3 inhibitor | 0.17 0.06 CID_4616 | ||
| 0.229 | 0.097 | 0.229 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.204 0.155 CID_4616 | ||
| 0.138 | 0.006 | 0.138 | Phosphodiesterase 3B inhibitor | |||
| 0.165 | 0.038 | 0.165 | MAP kinase kinase 4 inhibitor | 0.158 0.048 CID_4616 | ||
| 0.136 | 0.012 | 0.136 | Phosphodiesterase III inhibitor | |||
| 0.127 | 0.007 | 0.127 | NMDA receptor glycine site agonist | 0.108 0.013 CID_4616 | ||
| 0.123 | 0.004 | 0.123 | MDM2 inhibitor | 0.087 0.013 CID_4616 | ||
| 0.221 | 0.102 | 0.221 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.159 CID_4616 | ||
| 0.126 | 0.008 | 0.126 | NMDA receptor subunit 3B antagonist | 0.049 0.026 CID_4616 | ||
| 0.173 | 0.057 | 0.173 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.125 | 0.01 | 0.125 | Glutamate (mGluR1) antagonist | |||
| 0.23 | 0.116 | 0.23 | Insulysin inhibitor | |||
| 0.167 | 0.056 | 0.167 | Thiol protease inhibitor | |||
| 0.16 | 0.052 | 0.16 | Phosphodiesterase inhibitor | |||
| 0.141 | 0.037 | 0.192 | Protein kinase C gamma inhibitor | 0.192 0.016 CID_4616 | CID_4616 | |
| 0.109 | 0.005 | 0.109 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.113 | 0.009 | 0.113 | GABA B receptor agonist | 0.097 0.019 CID_4616 | ||
| 0.152 | 0.049 | 0.152 | Pregnane X receptor agonist | |||
| 0.142 | 0.041 | 0.142 | Ferrochelatase inhibitor | 0.099 0.072 CID_4616 | ||
| 0.166 | 0.068 | 0.166 | Neurotensin receptor agonist | 0.142 0.122 CID_4616 | ||
| 0.167 | 0.07 | 0.172 | Peroxidase inhibitor | 0.172 0.068 CID_4616 | CID_4616 | |
| 0.133 | 0.039 | 0.133 | Sphingosine 1-phosphate receptor 2 agonist | 0.104 0.09 CID_4616 | ||
| 0.199 | 0.105 | 0.199 | Aldehyde oxidase inhibitor | 0.161 0.129 CID_4616 | ||
| 0.11 | 0.016 | 0.11 | NMDA receptor agonist | 0.087 0.025 CID_4616 | ||
| 0.124 | 0.03 | 0.186 | Protein kinase C zeta inhibitor | 0.186 0.013 CID_4616 | CID_4616 | |
| 0.165 | 0.074 | 0.165 | Catenin beta inhibitor | 0.147 0.114 CID_4616 | ||
| 0.103 | 0.011 | 0.103 | AMPA receptor antagonist | 0.078 0.018 CID_4616 | ||
| 0.133 | 0.042 | 0.133 | EphA2 antagonist | |||
| 0.161 | 0.073 | 0.161 | Polo-like kinase-3 inhibitor | |||
| 0.097 | 0.009 | 0.097 | Cholecystokinin A antagonist | |||
| 0.113 | 0.028 | 0.113 | GABA A receptor agonist | |||
| 0.134 | 0.051 | 0.134 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.257 | 0.176 | 0.257 | Analgesic | 0.233 0.199 CID_4616 | ||
| 0.097 | 0.016 | 0.097 | Phospholipase D inhibitor | 0.066 0.063 CID_4616 | ||
| 0.143 | 0.063 | 0.143 | Sodium channel blocker | |||
| 0.089 | 0.01 | 0.116 | Cholecystokinin antagonist | 0.116 0.007 CID_4616 | CID_4616 | |
| 0.141 | 0.062 | 0.141 | Aurora-C kinase inhibitor | 0.122 0.1 CID_4616 | ||
| 0.192 | 0.114 | 0.252 | MAP-kinase-activated kinase 5 inhibitor | 0.252 0.058 CID_4616 | CID_4616 | |
| 0.178 | 0.101 | 0.178 | Neurotrophic factor enhancer | |||
| 0.105 | 0.029 | 0.105 | Phosphodiesterase 3A inhibitor | |||
| 0.181 | 0.105 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.079 | 0.004 | 0.234 | Benzodiazepine receptor peripheral-type antagonist | 0.234 0.002 CID_4616 | CID_4616 | |
| 0.086 | 0.01 | 0.086 | 5 Hydroxytryptamine 7 agonist | |||
| 0.094 | 0.019 | 0.094 | Cannabinoid CB1 receptor antagonist | |||
| 0.238 | 0.164 | 0.238 | Histamine release inhibitor | |||
| 0.117 | 0.043 | 0.117 | Creatine kinase inhibitor | 0.106 0.053 CID_4616 | ||
| 0.111 | 0.04 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.062 CID_4616 | ||
| 0.145 | 0.075 | 0.167 | MAP kinase 3 inhibitor | 0.167 0.046 CID_4616 | CID_4616 | |
| 0.117 | 0.048 | 0.165 | Beta glucuronidase inhibitor | 0.165 0.019 CID_4616 | CID_4616 | |
| 0.12 | 0.052 | 0.12 | Nav1.4 sodium channel blocker | 0.094 0.086 CID_4616 | ||
| 0.08 | 0.012 | 0.08 | NMDA receptor subunit 3A antagonist | |||
| 0.191 | 0.123 | 0.212 | DNA damaging | 0.212 0.106 CID_4616 | CID_4616 | |
| 0.111 | 0.044 | 0.155 | Electrolyte absorption antagonist | 0.155 0.018 CID_4616 | CID_4616 | |
| 0.075 | 0.008 | 0.075 | Benzodiazepine inverse agonist | 0.049 0.027 CID_4616 | ||
| 0.177 | 0.112 | 0.177 | Dyrk kinase inhibitor | |||
| 0.073 | 0.008 | 0.073 | Kainate receptor 2 antagonist | 0.047 0.018 CID_4616 | ||
| 0.11 | 0.046 | 0.11 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.137 | 0.073 | 0.137 | Cytokine production inhibitor | |||
| 0.094 | 0.031 | 0.094 | Cannabinoid receptor antagonist | |||
| 0.151 | 0.088 | 0.284 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.284 0.037 CID_4616 | CID_4616 | |
| 0.065 | 0.005 | 0.065 | NMDA receptor glycine site antagonist | 0.041 0.008 CID_4616 | ||
| 0.132 | 0.076 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.124 0.101 CID_4616 | ||
| 0.081 | 0.025 | 0.081 | Phosphodiesterase VII inhibitor | |||
| 0.082 | 0.026 | 0.082 | 5 Hydroxytryptamine 2A agonist | |||
| 0.172 | 0.116 | 0.172 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.14 | 0.086 | 0.14 | Diuretic | |||
| 0.073 | 0.021 | 0.073 | Phosphodiesterase 1A inhibitor | |||
| 0.084 | 0.032 | 0.084 | Potassium channel large-conductance Ca-activated activator | 0.061 0.058 CID_4616 | ||
| 0.066 | 0.015 | 0.066 | Bromodomain-containing protein 3 inhibitor | 0.048 0.037 CID_4616 | ||
| 0.151 | 0.1 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.074 | 0.023 | 0.074 | Cyclin D1 inhibitor | 0.056 0.05 CID_4616 | ||
| 0.098 | 0.048 | 0.098 | Histamine N-methyltransferase inhibitor | |||
| 0.085 | 0.035 | 0.085 | MAP kinase kinase 7 inhibitor | 0.078 0.053 CID_4616 | ||
| 0.183 | 0.134 | 0.183 | Spasmolytic | |||
| 0.14 | 0.092 | 0.14 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.127 0.124 CID_4616 | ||
| 0.076 | 0.028 | 0.076 | NMDA 2C receptor antagonist | |||
| 0.084 | 0.036 | 0.084 | Prostaglandin-E synthase inhibitor | |||
| 0.058 | 0.01 | 0.058 | Acid-sensing ion channel blocker | 0.042 0.025 CID_4616 | ||
| 0.06 | 0.013 | 0.06 | Factor XIa inhibitor | |||
| 0.119 | 0.072 | 0.119 | MAP kinase 12 inhibitor | 0.109 0.084 CID_4616 | ||
| 0.199 | 0.152 | 0.199 | 12-Lipoxygenase inhibitor | |||
| 0.056 | 0.011 | 0.056 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 CID_4616 | ||
| 0.095 | 0.051 | 0.095 | Phosphodiesterase I inhibitor | |||
| 0.076 | 0.031 | 0.076 | Aryl hydrocarbon receptor antagonist | |||
| 0.11 | 0.066 | 0.11 | Alpha 2b adrenoreceptor antagonist | |||
| 0.091 | 0.048 | 0.091 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.082 0.061 CID_4616 | ||
| 0.128 | 0.084 | 0.128 | Nav1.6 sodium channel blocker | |||
| 0.082 | 0.04 | 0.082 | Adenosine A3 receptor antagonist | |||
| 0.053 | 0.012 | 0.053 | 5 Hydroxytryptamine 2B agonist | |||
| 0.053 | 0.012 | 0.053 | p53 inhibitor | |||
| 0.151 | 0.111 | 0.151 | Succinate dehydrogenase inhibitor | 0.151 0.11 CID_4616 | ||
| 0.063 | 0.023 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.121 | 0.082 | 0.121 | NADPH oxidase inhibitor | |||
| 0.062 | 0.024 | 0.066 | Phosphorylase inhibitor | 0.066 0.022 CID_4616 | CID_4616 | |
| 0.13 | 0.094 | 0.13 | MAP3K9 inhibitor | 0.126 0.102 CID_4616 | ||
| 0.075 | 0.038 | 0.088 | Protein kinase C beta inhibitor | 0.088 0.021 CID_4616 | CID_4616 | |
| 0.185 | 0.149 | 0.185 | Neuropeptide Y2 antagonist | |||
| 0.056 | 0.02 | 0.056 | Adenylate cyclase 1 inhibitor | |||
| 0.063 | 0.028 | 0.079 | Cyclin B2 inhibitor | 0.079 0.015 CID_4616 | CID_4616 | |
| 0.094 | 0.06 | 0.112 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.112 0.044 CID_4616 | CID_4616 | |
| 0.078 | 0.044 | 0.086 | Protein kinase B beta inhibitor | 0.086 0.036 CID_4616 | CID_4616 | |
| 0.106 | 0.072 | 0.106 | MAP kinase 13 inhibitor | 0.098 0.084 CID_4616 | ||
| 0.059 | 0.025 | 0.059 | Adenosine A2b receptor antagonist | |||
| 0.045 | 0.012 | 0.045 | Factor XI inhibitor | 0.037 0.019 CID_4616 | ||
| 0.052 | 0.02 | 0.081 | Kainate receptor antagonist | 0.081 0.01 CID_4616 | CID_4616 | |
| 0.117 | 0.087 | 0.117 | Nav1.2 sodium channel blocker | |||
| 0.089 | 0.059 | 0.089 | Pim-3 kinase inhibitor | |||
| 0.09 | 0.062 | 0.09 | Polo-like kinase-1 inhibitor | |||
| 0.071 | 0.043 | 0.071 | Nav1.7 sodium channel blocker | |||
| 0.055 | 0.027 | 0.055 | Purinergic P2X antagonist | |||
| 0.148 | 0.122 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.059 | 0.033 | 0.059 | Pregnane X receptor antagonist | |||
| 0.101 | 0.075 | 0.108 | Cystathionine beta-synthase inhibitor | 0.108 0.068 CID_4616 | CID_4616 | |
| 0.047 | 0.023 | 0.047 | Histamine H1 receptor agonist | |||
| 0.063 | 0.039 | 0.079 | Cyclin B1 inhibitor | 0.079 0.023 CID_4616 | CID_4616 | |
| 0.055 | 0.032 | 0.055 | 5 Hydroxytryptamine 2 agonist | |||
| 0.044 | 0.021 | 0.044 | AMPA 4 receptor antagonist | 0.036 0.034 CID_4616 | ||
| 0.062 | 0.04 | 0.062 | Phosphodiesterase 1B inhibitor | |||
| 0.108 | 0.086 | 0.108 | MAP kinase kinase inhibitor | |||
| 0.051 | 0.029 | 0.051 | Histamine H4 receptor antagonist | |||
| 0.052 | 0.03 | 0.052 | Sodium/calcium exchanger inhibitor | |||
| 0.062 | 0.041 | 0.062 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.061 | 0.04 | 0.061 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.056 | 0.035 | 0.056 | Pim-2 kinase inhibitor | |||
| 0.056 | 0.036 | 0.073 | Cyclin B inhibitor | 0.073 0.019 CID_4616 | CID_4616 | |
| 0.067 | 0.047 | 0.067 | CDC7 inhibitor | |||
| 0.063 | 0.044 | 0.063 | 5 Hydroxytryptamine 3 agonist | |||
| 0.07 | 0.051 | 0.07 | NMDA 2 receptor antagonist | |||
| 0.101 | 0.082 | 0.101 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.131 | 0.112 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.129 0.124 CID_4616 | ||
| 0.046 | 0.028 | 0.046 | Parathyroid hormone antagonist | |||
| 0.072 | 0.055 | 0.072 | Protein kinase B gamma inhibitor | |||
| 0.057 | 0.041 | 0.057 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.086 | 0.071 | 0.086 | Glutamate release inhibitor | |||
| 0.062 | 0.046 | 0.062 | Purinergic P2 antagonist | |||
| 0.055 | 0.04 | 0.055 | Phosphodiesterase 4C inhibitor | |||
| 0.067 | 0.053 | 0.067 | I kappa B kinase 1 inhibitor | |||
| 0.093 | 0.081 | 0.093 | DNA intercalator | |||
| 0.032 | 0.019 | 0.032 | AMPA 1 receptor antagonist | |||
| 0.106 | 0.094 | 0.106 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.058 | 0.046 | 0.058 | Potassium channel (Ca-activated) blocker | |||
| 0.06 | 0.048 | 0.06 | Phosphodiesterase 1C inhibitor | |||
| 0.049 | 0.038 | 0.049 | NMDA 2A receptor antagonist | |||
| 0.112 | 0.101 | 0.112 | Interleukin 1 antagonist | |||
| 0.033 | 0.023 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.08 | 0.069 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.082 | 0.071 | 0.094 | NADH dehydrogenase inhibitor | 0.094 0.051 CID_4616 | CID_4616 | |
| 0.065 | 0.055 | 0.065 | Exportin-1 inhibitor | |||
| 0.086 | 0.076 | 0.086 | MAP kinase kinase 1 inhibitor | |||
| 0.048 | 0.039 | 0.048 | Potassium channel (Inward rectifier) activator | |||
| 0.046 | 0.038 | 0.046 | Potassium channel (ATP-sensitive) activator | |||
| 0.022 | 0.014 | 0.022 | Kainate receptor 1 antagonist | |||
| 0.039 | 0.031 | 0.039 | CDK5/p25 inhibitor | |||
| 0.028 | 0.021 | 0.038 | Cyclin E2 inhibitor | 0.038 0.013 CID_4616 | CID_4616 | |
| 0.142 | 0.136 | 0.142 | Death-associated protein kinase 3 inhibitor | |||
| 0.111 | 0.106 | 0.111 | CDC-like kinase 1 inhibitor | |||
| 0.024 | 0.018 | 0.024 | Kainate receptor 4 antagonist | |||
| 0.123 | 0.118 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.078 | 0.074 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.067 CID_4616 | CID_4616 | |
| 0.151 | 0.147 | 0.151 | MAP kinase kinase 5 inhibitor | |||
| 0.025 | 0.021 | 0.025 | Thymidine phosphorylase inhibitor | 0.024 0.023 CID_4616 | ||
| 0.098 | 0.093 | 0.098 | Photosensitizer | |||
| 0.067 | 0.063 | 0.067 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.07 | 0.066 | 0.07 | Vanilloid 4 agonist | |||
| 0.028 | 0.025 | 0.028 | Potassium channel small-conductance Ca-activated activator | |||
| 0.051 | 0.048 | 0.051 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.011 | 0.008 | 0.011 | CD80 antagonist | |||
| 0.074 | 0.072 | 0.074 | MAP-kinase-activated kinase inhibitor | |||
| 0.049 | 0.048 | 0.049 | Bromodomain-containing protein 4 inhibitor | |||
| 0.059 | 0.06 | 0.063 | Kallikrein 7 inhibitor | 0.063 0.046 CID_4616 | CID_4616 | |
| 0.025 | 0.028 | 0.061 | Cholecystokinin B antagonist | 0.061 0.008 CID_4616 | CID_4616 | |
| 0.042 | 0.056 | 0.088 | Plasminogen activator inhibitor | 0.088 0.021 CID_4616 | CID_4616 | |
| 0.042 | 0.06 | 0.082 | Protein kinase C eta inhibitor | 0.082 0.023 CID_4616 | CID_4616 | |
| 0.09 | 0.122 | 0.123 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.123 0.082 CID_4616 | CID_4616 | |
| 0.23 | 0.279 | 0.284 | Caspase 9 stimulant | 0.284 0.212 CID_4616 | CID_4616 | |
| 0.091 | 0.16 | 0.126 | Cell wall synthesis inhibitor | 0.126 0.091 CID_4616 | CID_4616 | |
| 0.057 | 0.131 | 0.142 | Protein kinase C mu inhibitor | 0.142 0.03 CID_4616 | CID_4616 | |
| 0.064 | 0.158 | 0.097 | Nav1.1 sodium channel blocker | 0.097 0.07 CID_4616 | CID_4616 | |
| 0.062 | 0.214 | 0.155 | Protein kinase C nu inhibitor | 0.155 0.067 CID_4616 | CID_4616 | |
| 0.078 | 0.267 | 0.161 | Interleukin 6 antagonist | 0.161 0.074 CID_4616 | CID_4616 | |
| 0.034 | 0.274 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 CID_4616 | CID_4616 | |
| 0.004 | 0.412 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.005 CID_4616 | CID_4616 | |
| 0.013 | 0.703 | 0.178 | Antioxidant | 0.178 0.134 CID_4616 | CID_4616 | |
| 0.005 | 0.804 | 0.167 | Lipid peroxidase inhibitor | 0.167 0.057 CID_4616 | CID_4616 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |